Skip to content
10-Q

Quarterly Report

BioRestorative Therapies, Inc. BRTX

0001641172-25-023211

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 7.98M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.74M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.55M sh
Shares Diluted Q2 2025 · Jun 30, 2024 8.12M sh
Shares Diluted Q2 2025 · Jun 30, 2024 7.4M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2025 $36.4K
Capex Q2 2025 · Jun 30, 2024 $35.3K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$5.47M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.18M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.56M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $547.89K
Stockholders Equity Q2 2025 · Jun 30, 2025 $4.85M
Stockholders Equity Q2 2025 · Mar 31, 2025 $6.14M
Stockholders Equity Q2 2025 · Dec 31, 2024 $8.53M
Stockholders Equity Q2 2025 · Jun 30, 2024 $10.8M
Stockholders Equity Q2 2025 · Mar 31, 2024 $14.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 $10M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.67M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.75M
Total Liabilities Q2 2025 · Jun 30, 2025 $3.67M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.75M
Current Assets Q2 2025 · Jun 30, 2025 $7.6M
Current Assets Q2 2025 · Dec 31, 2024 $11.14M
Total Assets Q2 2025 · Jun 30, 2025 $8.52M
Total Assets Q2 2025 · Dec 31, 2024 $12.28M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.94
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.50
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.84
Eps Basic Q2 2025 · Jun 30, 2025 −$0.30
Eps Basic Q2 2025 · Jun 30, 2025 −$0.94
Eps Basic Q2 2025 · Jun 30, 2024 −$0.50
Eps Basic Q2 2025 · Jun 30, 2024 −$0.84
Sga Expense Q2 2025 · Jun 30, 2025 $1.37M
Sga Expense Q2 2025 · Jun 30, 2025 $3.56M
Sga Expense restated Q2 2025 · Jun 30, 2024 $1.1M
Sga Expense restated Q2 2025 · Jun 30, 2024 $3.16M
Rd Expense Q2 2025 · Jun 30, 2025 $2.23M
Rd Expense Q2 2025 · Jun 30, 2025 $4.87M
Rd Expense restated Q2 2025 · Jun 30, 2024 $1.45M
Rd Expense restated Q2 2025 · Jun 30, 2024 $3.53M
Net Income Q2 2025 · Jun 30, 2025 −$2.66M
Net Income Q2 2025 · Jun 30, 2025 −$8M
Net Income Q2 2025 · Mar 31, 2025 −$5.34M
Net Income Q2 2025 · Jun 30, 2024 −$4.03M
Net Income Q2 2025 · Jun 30, 2024 −$6.25M
Net Income Q2 2025 · Mar 31, 2024 −$2.22M
Operating Income Q2 2025 · Jun 30, 2025 −$3.31M
Operating Income Q2 2025 · Jun 30, 2025 −$8.11M
Operating Income Q2 2025 · Jun 30, 2024 −$2.47M
Operating Income Q2 2025 · Jun 30, 2024 −$6.58M
Gross Profit Q2 2025 · Jun 30, 2025 $294.57K
Gross Profit Q2 2025 · Jun 30, 2025 $316.66K
Gross Profit Q2 2025 · Jun 30, 2024 $82.61K
Gross Profit Q2 2025 · Jun 30, 2024 $117.61K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $8.73K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11.64K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $6.49K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $6.49K
Revenue Q2 2025 · Jun 30, 2025 $303.3K
Revenue Q2 2025 · Jun 30, 2025 $328.3K
Revenue Q2 2025 · Jun 30, 2024 $89.1K
Revenue Q2 2025 · Jun 30, 2024 $124.1K